About the home testing kit
Our Genetic Screening test identifies men at high risk of developing prostate cancer, this is identified by detection of fault genes which are known to increase risk. A simple at home saliva test that is then sent to our laboratory for analysis.
£550.00
Please complete the information below to place an order, please ensure that these details are for the patient that will be taking the test.
Out of stock
About Prostate Cancer
About Prostate Cancer
Prostate Cancer begins when the cells in the prostate gland start to grow uncontrollably. The abnormal cells when left untreated, can form tumours which may spread to other parts of the body, but for most men, it is a relatively slow growing disease.
Receiving your order
Receiving your order
Shipment costs to you are covered within the cost of your test.
Orders placed before 14:00 Monday to Thursday will be despatched the same day for next working day delivery. Any orders placed out of this time please allow 2-3 working days for delivery.
If you are ordering after 14:00 on a Friday your test kit will be despatched Monday. Orders are not despatched during the weekend or Bank Holidays.
Deliveries to you during Bank Holidays
Unfortunately due to couriers not operating during the Bank Holiday there will be delays in sending test kits out to home/isolation addresses. No dispatches of self test kits will take place after 14:00pm on Friday. Dispatching of test kits will resume to normal on the returning Tuesday.
Collection Method
Collection Method
Our Genetic Screening test for Prostate cancer is a simple saliva sample. A small amount of spit is required for us to carry out the screening.
How to take the test
How to take the test
A sample tube and attachment will be inside your kit to make the process as easy as possible. Fill the level to 2.5ml (without bubbles) screw the cap back onto the sample tube and pack the sample into the free postage envelope provided. Take the sample to your nearest post office and await notification of your sample arriving at the lab.
How will I receive my results?
How will I receive my results?
Results take just 5-7 working days from receipt of your sample at the laboratory.
Your results will be sent to you via our secure online portal, when you place your order you will receive two emails:
- Confirmation of your order
- Invitation to create your online secure account.
You will be prompted on screen to create your account and create a password (don’t forget to make a note of these). When your result is ready you will receive an email notification to alert you that your test has been updated. - Please note if a positive lev el is detected we will call you to discuss first and then update your online results account.
Head over to the secure account and log in to view your test result.
Your results document will be sent in PDF format allowing you to easily download and print.
About the lab
About the lab
Our partner laboratory provides precision oncology testing to address demand for personalised cancer medicine. This enables cancer patients to be matched to the most appropriate targeted therapies and immunotherapies based on their unique tumour mutation profiles.
They also provide COVID-19 testing services and viral sequencing to track new SARS COVID-19 variants.
The lab was founded in 2014 with a mission to harness molecular sequencing technologies to deliver an increased range of personalised medicine opportunities to patients with cancer.
Being one of the first clinically approved laboratories in Europe to harness the power of genomic profiling to deliver personalised cancer medicine. This enables the most comprehensive linkage of specific cancer genetic mutations to the most appropriate targeted therapy.
They are at the forefront of providing precision oncology services that help ensure patients derive maximum benefit from a new generation of personalised drugs and also functions as a Contract Research Organisation (CRO) to support biomarker and drug development programmes. Their proven portfolio of comprehensive genomic profiling and tumour based assays are used to support theranostic programmes at all stages of the cancer development, from discovery through preclinical development to clinical trials.
